SCM
VKTX icon

Sio Capital Management’s Viking Therapeutics VKTX Stock Holding History

Sio Capital Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-595,002
Closed -$6.59M – 59
2023
Q3 		$6.59M Buy
595,002
+67,345
+13% +$963K 2.04% 18
2023
Q2 		$8.55M Buy
527,657
+277,657
+111% +$5.82M 2.18% 14
2023
Q1 		$4.16M Buy
+250,000
New +$2.58M 2.06% 11
2022
Q3 		– Sell
-999,829
Closed -$2.89M – 60
2022
Q2 		$2.89M Hold
999,829
– – 1.09% 27
2022
Q1 		$3M Buy
999,829
+339,016
+51% +$1.22M 0.99% 27
2021
Q4 		$3.04M Hold
660,813
– – 0.92% 29
2021
Q3 		$4.15M Buy
660,813
+41,033
+7% +$253K 1.32% 25
2021
Q2 		$3.71M Buy
619,780
+50,000
+9% +$297K 0.92% 38
2021
Q1 		$3.6M Sell
569,780
-40,000
-7% -$281K 0.73% 45
2020
Q4 		$3.43M Sell
609,780
-100,000
-14% -$606K 0.7% 50
2020
Q3 		$4.13M Hold
709,780
– – 0.82% 41
2020
Q2 		$5.12M Sell
709,780
-42,461
-6% -$282K 1.49% 26
2020
Q1 		$3.52M Buy
752,241
+20,788
+3% +$128K 1.18% 27
2019
Q4 		$5.87M Sell
731,453
-23,306
-3% -$170K 1.4% 22
2019
Q3 		$5.19M Hold
754,759
– – 1.67% 21
2019
Q2 		$6.26M Sell
754,759
-97,401
-11% -$832K 1.51% 23
2019
Q1 		$8.47M Buy
852,160
+215,114
+34% +$1.8M 2.29% 16
2018
Q4 		$4.87M Buy
637,046
+423,794
+199% +$5.07M 1.78% 22
2018
Q3 		$3.71M Sell
213,252
-68,052
-24% -$810K 1.27% 29
2018
Q2 		$2.67M Sell
281,304
-995,541
-78% -$6.62M 1.48% 30
2018
Q1 		$5.58M Buy
1,276,845
+26,595
+2% +$147K 3.35% 10
2017
Q4 		$5.08M Buy
+1,250,250
New +$3.63M 2.86% 8
2016
Q4 		– Sell
-849,905
Closed -$1.19M – 49
2016
Q3 		$1.19M Buy
849,905
+295,523
+53% +$391K 0.82% 28
2016
Q2 		$699K Buy
+554,382
New +$731K 0.36% 37

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sio Capital Management's VKTX Position: Q4 2023 in Review

Sio Capital Management sold out of Viking Therapeutics (VKTX) in Q4 2023, closing a stake of 595,002 shares — an estimated $6.59M sold.

Sio Capital Management first reported a position in VKTX in Q2 2016 and held it in 24 quarters. The position peaked at $8.55M in Q2 2023. 197 funds tracked by Wall St. Rank hold VKTX as of Q4 2023.

  • Sio Capital Management reported no remaining Viking Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Sio Capital Management sold 595,002 Viking Therapeutics shares in Q4 2023, an estimated $6.59M.
  • Sio Capital Management first reported a position in Viking Therapeutics in Q2 2016 and held it in 24 quarters.
  • Sio Capital Management's Viking Therapeutics position peaked at $8.55M in Q2 2023.
  • 197 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2023.

Based on Sio Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.